Mitigating Unexpected Trial Disruptions With a Flexible CTMS Delivery Model As we enter the eighth month of the COVID-19 pandemic, businesses in numerous industries are feeling the financial consequences of the disruption of normal operations. For clinical trials, many studies have been either slowed, suspended or even terminated due to safety precautions for participants and …
Continue reading “Bioclinica: Bring Clarity to your Clinical Trials”